Stocktoria

OMEROS CORP OMER

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2009-10-08 · LEI

OMEROS CORP financials (annual)

Revenue
$41.6M $64.8M $29.9M $111.8M $73.8M 2016201720182019202020212022202320242025
Net income
-$66.7M -$53.5M -$126.8M -$84.5M -$138.1M $194.2M $47.4M -$117.8M -$156.8M -$3.4M 2016201720182019202020212022202320242025
Free cash flow
-$51.6M -$36.6M -$104.3M -$60.4M -$100.4M -$110.0M -$86.6M $74.3M -$149.0M -$116.2M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$73.8M$111.8M$29.9M$64.8M$41.6M
R&D expense$81.3M$119.5M$114.9M$112.7M$118.8M$107.6M$106.3M$89.9M$55.6M$50.7M
SG&A expense$41.5M$47.4M$49.7M$50.7M$54.8M
Operating income-$122.8M-$167.0M-$164.5M-$163.4M-$173.6M-$156.9M-$146.0M-$112.2M-$43.9M-$54.3M
Interest expense$30.8M$22.7M$19.7M$26.8M$22.7M$16.3M$11.0M$7.8M
Income tax$2.0M$2.3M$0$0$0-$23.3M-$19.8M-$12.9M$0$0
Net income-$3.4M-$156.8M-$117.8M$47.4M$194.2M-$138.1M-$84.5M-$126.8M-$53.5M-$66.7M
EPS (diluted)$-0.05$-2.70$-1.88$0.76$3.12$-2.41$-1.71
Operating cash flow-$116.1M-$148.8M$74.7M-$86.5M-$109.7M-$100.1M-$60.1M-$103.7M-$36.2M-$51.5M
Free cash flow-$116.2M-$149.0M$74.3M-$86.6M-$110.0M-$100.4M-$60.4M-$104.3M-$36.6M-$51.6M
Cash & equivalents$9.7M$3.4M$7.1M$11.0M$100.8M$10.5M$3.1M$5.9M$3.4M$2.2M
Inventory$0$1.4M$1.1M$88,000$443,000$1.1M
Total assets$325.6M$277.1M$378.3M$591.0M$419.3M$181.0M$137.0M$95.9M$116.3M$67.3M
Shareholders' equity-$121.2M-$182.6M-$25.0M$85.7M$23.8M-$120.8M-$109.0M-$100.2M-$2.8M-$37.4M

Growth · year-over-year · Revenue CAGR 15.4%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-34.0%+274.3%-53.9%+55.8%+208.1%
Net income growth-348.5%-75.6%
EPS growth-347.4%-75.6%
Free cash flow growth-300.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.